Global HLA Typing for Transplant Market Size, Growth, Opportunity and Forecast
-
Product Code:
RP-ID-10008364 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
143 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-12
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
The global HLA Typing for Transplant Market was valued at USD 533.78 million in 2016 and is projected to reach USD 970.65 million by 2025, growing at a CAGR of 6.87% from 2017 to 2025.
Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. Due to increasing transplant failures there is a rising need to match the organ transplant feasibility before the surgery to avoid any kind of loss. There are increasing fund in the HLA Typing market from the side of Govt. as well as Pvt. Sector.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growing number of Tissue and Organ transplantations
1.2 Growing technical support and discoveries in HLA Typing
1.3 Growing Funds from both Government and Private sector
2. Market Restraints
2.1 High technology associated costs
2.2 Limited reimbursements
2.3 High cost of techniques like PCR
Market Segmentation:
1. Global HLA Typing for Transplant Market, by Applications:
1.1 Research applications
1.2 Diagnostic Applications
2. Global HLA Typing for Transplant Market, by Products and Services:
2.1 Reagents and Consumables
2.2 Software and Services
2.3 Instruments
3. Global HLA Typing for Transplant Market, by End User:
3.1 Commercial Service Providers
3.2 Research Laboratories and Academic Institutes
3.3 Hospitals and Transplant Centers
4. Global HLA Typing for Transplant Market, by Technology:
4.1 Non Molecular Assays
4.1.1 Mixed Lymphocyte Culture (MLC) Assays
4.1.2 Serological Assays
4.2 Molecular Assays
4.2.1 Sequencing Based
4.2.1.1 Next-Generation Sequencing (NGS)
4.2.1.2 Sanger Sequencing
4.2.2 PCR Based
4.2.2.1 Sequence-Specific Oligonucleotide (SSO)-PCR
4.2.2.2 Sequence-Specific Primer (SSP)-PCR
5. Global HLA Typing for Transplant Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific, Inc.
2. Immucor, Inc.
3. Olerup SSP AB
4. Qiagen N.V.
5. Bio-Rad Laboratories, Inc.
6. Illumina, Inc.
7. Affymetrix, Inc.
8. F. Hoffmann-LA-Roche Limited
9. Luminex Corporation
10. Abbott Laboratories, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the HLA Typing for Transplant Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
Please enter your personal details below
2. Immucor, Inc.
3. Olerup SSP AB
4. Qiagen N.V.
5. Bio-Rad Laboratories, Inc.
6. Illumina, Inc.
7. Affymetrix, Inc.
8. F. Hoffmann-LA-Roche Limited
9. Luminex Corporation
10. Abbott Laboratories, Inc.